icjulavj | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/icjulavj_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Zingone%2C_Fabiana%3B_Buda%2C_Andrea%3B_Savarino%2C_Edoardo>
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.dld.2020.09.020>
?:doi	10.1016/j.dld.2020.09.020
?:journal	Dig_Liver_Dis
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/c50f91417cd2858482cd8c0176b11cabbd7a2cb1.json
?:pmc_json_files	document_parses/pmc_json/PMC7547636.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7547636>
?:pmid	<https://research.tib.eu/covid-19/entity/33051162.0>
?:pmid	33051162.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/c50f91417cd2858482cd8c0176b11cabbd7a2cb1>
?:source	Elsevier; Medline; PMC
?:title	Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-10

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/icjulavj>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/icjulavj>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all